Modified mGluR6 Promoter for Targeted Retinal Bipolar Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing gene therapy methods struggle to efficiently target and express transgenes, such as photosensitive proteins, in specific inner retinal neurons for ocular therapy, necessitating improved regulatory elements and expression vectors.
Innovation Solution
Utilization of modified metabotropic glutamate receptor 6 (mGluR6) promoters, including enhancer and promoter fragments, along with intron sequences, to enhance and target transgene expression specifically to ON bipolar cells in the retina, using adeno-associated virus (AAV) vectors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional promoters are used for gene delivery, then the delivery system is simple, but the targeting efficiency to specific inner retinal neurons is poor
Solution Approach 1:
The promoter is divided into functional segments including the core promoter, mGluR6 enhancer, and intron sequences. This segmentation allows each component to contribute specific functions: the core promoter initiates transcription, the enhancer provides cell-type-specific activation, and the introns contribute to proper expression patterns. This modular approach achieves precise targeting to ON bipolar cells while maintaining manageable complexity through functional decomposition.
Solution Approach 2:
The mGluR6 promoter incorporates cell-type-specific regulatory elements (enhancer and intron sequences) that create local quality differences in gene expression. These sequences are specifically active in ON bipolar cells, ensuring that the transgene is expressed only in the desired cell type. This local quality approach enables precise spatial and temporal control of gene expression in the retina.
2Productivity
If generic expression vectors are used, then the vector system is simple, but the expression efficiency in retinal bipolar cells is insufficient
Solution Approach 1:
The expression vector merges multiple regulatory components (core promoter, mGluR6 enhancer, intron sequences) into a single functional unit that drives high-level expression in retinal bipolar cells. This merging of elements creates a synergistic effect where the combined regulatory sequence achieves superior expression efficiency compared to any individual component alone, while remaining integrated within a manageable vector system.
Solution Approach 2:
The vector system utilizes parameter changes in the regulatory sequences, particularly the mGluR6 enhancer and intron regions, to optimize expression levels. By modifying these sequence parameters (length, composition, arrangement), the system achieves enhanced transcriptional activity and protein expression specifically in ON bipolar cells, transforming generic vector performance into cell-specific high-efficiency expression.
3Reliability
If transgenes are delivered without specific regulatory elements, then the delivery process is simple, but the light sensitivity and visual function improvement are limited
Solution Approach 1:
The mGluR6 promoter sequences (enhancer and intron) are prepared and positioned in advance within the expression vector before transgene delivery. This preliminary arrangement of regulatory elements ensures that once the vector is delivered to retinal bipolar cells, transcription and expression are immediately activated with high efficiency. The pre-positioned regulatory sequences eliminate the need for post-delivery manipulation and ensure reliable functional improvement from the outset.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The invention provides nucleic acids and nucleic acid expression vectors containing optimized mGluR6 promoters for expression of transgenes in the retina. The compositions and methods of the invention are useful for expression of gene products to preserve, improve, or restore phototransduction or vision.